Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Felicia Owusu-Antwi

Biographic Data

ID7782737
NAMEFelicia Owusu-Antwi
GIVEN NAMESFelicia
FAMILY NAMEOwusu-Antwi
SIGNATUREOWUSU-ANTWI F
AFFILIATIONSGhana Health Service
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023

    Open Access•Benjamin Abuaku, Paul Boateng et al.•ARTICLE•Frontiers in Public Health•2026

    Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…

  • Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021

    Open Access•Michael Rockson Adjei, Kwame Amponsa-Achiano et al.•ARTICLE•BMC Public Health•2023

    The malaria vaccine has been piloted successfully in Ghana. Intensive advocacy; community engagement, and social mobilization; and regular onsite supportive supervision are critical enablers for successful introduction of new vaccines. Stakeholders are convinced of the feasibility of a nationwide scale up using a phased subnational approach taking into consideration malaria epidemiology and global availability of vaccines

No prominent works on this page.

  • Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021

    Open Access•Michael Rockson Adjei, Kwame Amponsa-Achiano et al.•ARTICLE•BMC Public Health•2023

    The malaria vaccine has been piloted successfully in Ghana. Intensive advocacy; community engagement, and social mobilization; and regular onsite supportive supervision are critical enablers for successful introduction of new vaccines. Stakeholders are convinced of the feasibility of a nationwide scale up using a phased subnational approach taking into consideration malaria epidemiology and global availability of vaccines

  • Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023

    Open Access•Benjamin Abuaku, Paul Boateng et al.•ARTICLE•Frontiers in Public Health•2026

    Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…

Malaria (2 works) · Biostatistics (1 work) · Clinical trial (1 work) · Combination therapy (1 work) · COVID-19 epidemiological studies (1 work) · Diverse Scientific Research Studies (1 work) · Environmental health (1 work) · Epidemiology (1 work) · Immunology (1 work) · Internal Medicine (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae